Table 5.
Treatment | GSH (U/mg protein) |
SOD (U/mg protein) |
CAT (U/mg protein) |
MDA (ng/mg protein) |
Nitrite | Hexose sugar |
Sialic | Acid phosphatase (U/l) |
Prostatic phosphatase (U/l) |
Untreated control | 1.38 ± 0.20 | 1.89 ± 0.16 | 13.27 ± 2.67 | 0.02 ± 0.00 | 8.62 ± 1.24 |
522.90 ± 10.17 |
199.70 ± 2.58 |
67.20 ± 11.77 |
60.50±13.43 |
Arthritic control | 1.07 ± 0.22d | 1.09 ± 0.10d | 12.34 ± 0.92 | 0.09 ± 0.00c | 11.17 ± 0.77 |
676.40 ± 7.49 |
378.70 ± 5.92c |
134.10 ± 10.96c |
94.71±2.36a |
100 mg/kg HEAC (Pre) |
1.19 ± 0.15a | 2.10 ± 0.52 a | 13.00 ± 1.15 | 0.02 ± 0.00d | 7.09 ± 0.50 |
558.90 ± 16.93 |
338.80 ± 4.30b |
76.02 ± 18.68e |
53.93±10.61d |
200 mg/kg HEAC (Pre) |
1.59 ± 0.15 a | 2.14 ± 0.50a | 14.39 ± 2.03 | 0.02 ± 0.00d | 10.53 ± 1.68 |
576.50 ± 53.33 |
199.70 ± 22.52e |
79.29 ± 2.12e |
41.34±1.04e |
400 mg/kg HEAC (Pre) |
1.36 ± 0.19a | 4.00 ± 0.20b | 15.39 ± 2.03 | 0.03 ± 0.01d | 7.98 ± 0.67 |
462.00 ± 14.91e |
81.78 ± 10.11f |
63.05±10.22e | 68.34±3.38d |
200 mg/kg HEAC (Post) |
1.48 ± 0.19a | 1.61 ± 0.15 | 17.03 ± 1.00 | 0.06 ± 0.02 | 10.32 ± 1.19 |
855.00 ± 71.66b |
318.80 ± 39.54b, d |
74.23±1.80e | 63.36±0.24d |
400 mg/kg HEAC (Post) |
2.48 ± 0.46c | 3.03 ± 0.60b | 15.36 ± 2.85 | 0.04 ± 0.00d | 10.76 ± 0.07 |
515.50 ± 61.77d |
250.50 ± 18.68a, d |
75.28±14.61e | 79.05±1.08d |
3 mg/kg CELE | 1.66 ± 0.27a | 1.54 ± 0.35 | 8.72 ± 0.63 | 0.02 ± 0.002d | 10.78 ± 0.29 |
536.80 ± 7.86 |
235.60 ± 13.97a, d |
42.96±7.19f | 21.75±1.06f |
represent significant increases at p<0.05, p<0.01 and p<0.001, respectively, when compared to untreated control. d, e and f represent significant decreases at p<0.05, p<0.01 and p<0.001 when compared to arthritic control values